Literature DB >> 24237305

NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress.

C Wei1, L Li, I K Kim, P Sun, S Gupta.   

Abstract

Oxidative stress, defined as an excess production of reactive oxygen species (ROS), is shown to play an important role in the pathophysiology of cardiac remodeling including cell death and contractile dysfunction. Therefore, the balance between ROS production and removal of excess ROS is essential in maintaining the redox state and homeostasis balance in the cell. The increased ROS further activates nuclear factor-κB (NF-κB), a redox-sensitive transcription factor and promotes cell death. Recently, microRNAs (miRNAs) have been identified as critical regulators of various pathophysiological processes of cardiac remodeling; however, NF-κB-mediated miRNA's role in cardiomyocytes under oxidative stress remains undetermined. The miR-21 has been implicated in diverse cardiac remodeling; but, NF-κB-mediated miR-21 modulation in oxidative stress is currently unknown. Neonatal cardiomyocytes were transfected with IκBα mutant, miR-21 mimetic, and inhibitors separately, and were challenged with H2O2. The target gene, programmed cell death 4 (PDCD4), ROS activity, and NF-κB translocation were analyzed. Our results indicated that NF-κB positively regulated miR-21 expression under oxidative stress, and PDCD4 was a direct target for miR-21. NF-κB further regulated the expression of PDCD4 in H2O2-induced oxidative stress. Moreover, H2O2-induced ROS activity and cardiomyocytes apoptosis were partly protected by overexpression of miR-21 and displayed an important role in ROS-mediated cardiomyocytes injury. We evaluated a critical role of NF-κB-mediated miR-21 modulation in H2O2-induced oxidative stress in cardiomyocytes by targeting PDCD4. Our data may provide a new insight of miR-21's role in cardiac diseases primarily mediated by ROS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24237305     DOI: 10.3109/10715762.2013.865839

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  38 in total

Review 1.  Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.

Authors:  Joshua Mayourian; Delaine K Ceholski; David M Gonzalez; Timothy J Cashman; Susmita Sahoo; Roger J Hajjar; Kevin D Costa
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

2.  Circulating miRNAs and their target genes associated with arsenism caused by coal-burning.

Authors:  Baofei Sun; Junchao Xue; Jun Li; Fei Luo; Xiong Chen; Yonglian Liu; Qingling Wang; Caihua Qi; Zhonglan Zou; Aihua Zhang; Qizhan Liu
Journal:  Toxicol Res (Camb)       Date:  2017-01-23       Impact factor: 3.524

3.  MiR-21 derived from the exosomes of MSCs regulates the death and differentiation of neurons in patients with spinal cord injury.

Authors:  Jian Kang; Zhenhuan Li; Zhongzheng Zhi; Shiqiang Wang; Guanghui Xu
Journal:  Gene Ther       Date:  2019-09-30       Impact factor: 5.250

4.  Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions.

Authors:  Hong Jin; Daniel Y Li; Ekaterina Chernogubova; Changyan Sun; Albert Busch; Suzanne M Eken; Peter Saliba-Gustafsson; Hanna Winter; Greg Winski; Uwe Raaz; Isabel N Schellinger; Nancy Simon; Renate Hegenloh; Ljubica Perisic Matic; Maja Jagodic; Ewa Ehrenborg; Jaroslav Pelisek; Hans-Henning Eckstein; Ulf Hedin; Alexandra Backlund; Lars Maegdefessel
Journal:  Mol Ther       Date:  2018-01-31       Impact factor: 11.454

5.  Inhibition of lncRNA Neat1 by catalpol via suppressing transcriptional activity of NF-κB attenuates cardiomyocyte apoptosis.

Authors:  Guoliang Zou; Weili Zhong; Fan Wu; Xiaoxue Wang; Li Liu
Journal:  Cell Cycle       Date:  2019-11-17       Impact factor: 4.534

Review 6.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

Review 7.  Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.

Authors:  Richard Seonghun Nho
Journal:  Drug Dev Res       Date:  2015-08-25       Impact factor: 4.360

Review 8.  European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).

Authors:  Javier Egea; Isabel Fabregat; Yves M Frapart; Pietro Ghezzi; Agnes Görlach; Thomas Kietzmann; Kateryna Kubaichuk; Ulla G Knaus; Manuela G Lopez; Gloria Olaso-Gonzalez; Andreas Petry; Rainer Schulz; Jose Vina; Paul Winyard; Kahina Abbas; Opeyemi S Ademowo; Catarina B Afonso; Ioanna Andreadou; Haike Antelmann; Fernando Antunes; Mutay Aslan; Markus M Bachschmid; Rui M Barbosa; Vsevolod Belousov; Carsten Berndt; David Bernlohr; Esther Bertrán; Alberto Bindoli; Serge P Bottari; Paula M Brito; Guia Carrara; Ana I Casas; Afroditi Chatzi; Niki Chondrogianni; Marcus Conrad; Marcus S Cooke; João G Costa; Antonio Cuadrado; Pham My-Chan Dang; Barbara De Smet; Bilge Debelec-Butuner; Irundika H K Dias; Joe Dan Dunn; Amanda J Edson; Mariam El Assar; Jamel El-Benna; Péter Ferdinandy; Ana S Fernandes; Kari E Fladmark; Ulrich Förstermann; Rashid Giniatullin; Zoltán Giricz; Anikó Görbe; Helen Griffiths; Vaclav Hampl; Alina Hanf; Jan Herget; Pablo Hernansanz-Agustín; Melanie Hillion; Jingjing Huang; Serap Ilikay; Pidder Jansen-Dürr; Vincent Jaquet; Jaap A Joles; Balaraman Kalyanaraman; Danylo Kaminskyy; Mahsa Karbaschi; Marina Kleanthous; Lars-Oliver Klotz; Bato Korac; Kemal Sami Korkmaz; Rafal Koziel; Damir Kračun; Karl-Heinz Krause; Vladimír Křen; Thomas Krieg; João Laranjinha; Antigone Lazou; Huige Li; Antonio Martínez-Ruiz; Reiko Matsui; Gethin J McBean; Stuart P Meredith; Joris Messens; Verónica Miguel; Yuliya Mikhed; Irina Milisav; Lidija Milković; Antonio Miranda-Vizuete; Miloš Mojović; María Monsalve; Pierre-Alexis Mouthuy; John Mulvey; Thomas Münzel; Vladimir Muzykantov; Isabel T N Nguyen; Matthias Oelze; Nuno G Oliveira; Carlos M Palmeira; Nikoletta Papaevgeniou; Aleksandra Pavićević; Brandán Pedre; Fabienne Peyrot; Marios Phylactides; Gratiela G Pircalabioru; Andrew R Pitt; Henrik E Poulsen; Ignacio Prieto; Maria Pia Rigobello; Natalia Robledinos-Antón; Leocadio Rodríguez-Mañas; Anabela P Rolo; Francis Rousset; Tatjana Ruskovska; Nuno Saraiva; Shlomo Sasson; Katrin Schröder; Khrystyna Semen; Tamara Seredenina; Anastasia Shakirzyanova; Geoffrey L Smith; Thierry Soldati; Bebiana C Sousa; Corinne M Spickett; Ana Stancic; Marie José Stasia; Holger Steinbrenner; Višnja Stepanić; Sebastian Steven; Kostas Tokatlidis; Erkan Tuncay; Belma Turan; Fulvio Ursini; Jan Vacek; Olga Vajnerova; Kateřina Valentová; Frank Van Breusegem; Lokman Varisli; Elizabeth A Veal; A Suha Yalçın; Olha Yelisyeyeva; Neven Žarković; Martina Zatloukalová; Jacek Zielonka; Rhian M Touyz; Andreas Papapetropoulos; Tilman Grune; Santiago Lamas; Harald H H W Schmidt; Fabio Di Lisa; Andreas Daiber
Journal:  Redox Biol       Date:  2017-05-18       Impact factor: 11.799

9.  Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway.

Authors:  Junchen Li; Lixun Huang; Zinan He; Minggui Chen; Yi Ding; Yuying Yao; Youfa Duan; Li Zixuan; Cuiling Qi; Lingyun Zheng; Jiangchao Li; Rongxin Zhang; Xiaoming Li; Jianwei Dai; Lijing Wang; Qian-Qian Zhang
Journal:  Front Cell Dev Biol       Date:  2021-06-23

10.  MiR-28 inhibits cardiomyocyte survival through suppressing PDK1/Akt/mTOR signaling.

Authors:  Rui-Yao Zhu; Di Zhang; Han-Dong Zou; Xiao-Shu Zuo; Qing-Shan Zhou; He Huang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-06-23       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.